Havrix 1,440 unit/ML syringeml

Ended Awarded

Contract number
SPE2DB23FK8LH
Awardee
Awarding agency
Obligated
$813

Award facts

Contract value 100% obligated
$813.36 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

DMS Pharmaceutical Group Inc. was awarded an $813 firm fixed price delivery order against the Defense Logistics Agency's Pharmaceutical Prime Vendor contract to supply 1,440 unit/mL syringes of HAVRIX, a hepatitis A vaccine. Performance will take place in Park Ridge, Illinois with all supplies delivered by February 6, 2023. No set-aside provisions were applied to this order for pharmaceutical products stocked under the Agency's prime vendor program, which leverages commercial distributors to maintain domestic and overseas medical supply chains.

Quick answers

Who was awarded contract SPE2DB23FK8LH?

SPE2DB23FK8LH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 3, 2023.

How much is contract SPE2DB23FK8LH worth?

The government has obligated $813 on SPE2DB23FK8LH.

Is contract SPE2DB23FK8LH an order under another contract?

Yes. SPE2DB23FK8LH is a delivery order under SPE2DB22D9330, an indefinite delivery contract.

Was contract SPE2DB23FK8LH competed?

The extent of competition for SPE2DB23FK8LH was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award